Rapport Therapeutics, Inc. Stock Performance
as on October 3, 2026 at 2:16 pm IST
Day's Low
Day's High
$31.77$33.66
1.24%
Downside
4.63%
Upside
52 Week's Low
52 Week's High
$23.75$52.9326.17%
Downside
64.53%
Upside
Rapport Therapeutics, Inc. share price movements today
- Previous Close
- $32.83
- Open
- $33.66
- Volume
- 274.1K
- Market Cap
- $1.6B
- Day's Low - High
- $31.77 - $33.66
- 52 Week Low - High
- $23.75 - $52.93
Rapport Therapeutics, Inc. Historical Returns
- 1 Month Return
- -32.49 %
- 3 Month Return
- -17.45 %
- 1 Year Return
- + 12.72 %
- 3 Year Return
- 0 %
- 5 Year Return
- 0 %
Rapport Therapeutics, Inc. Stock Fundamentals & Key Indicators
Check Rapport Therapeutics, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$1.6B
EPS (TTM)
-3.04
Dividend Yield
0.00%
PE Ratio (TTM)
-11.01
Industry PE ratio
-6.16
PEG Ratio
0.51
Return On Equity TTM
-29.02%
Rapport Therapeutics, Inc. vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Rapport Therapeutics, Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| StrongBuy | $1.6B | NA | -11.01 | 100.00% | 0.00% | |
| StrongBuy | $44.1B | 609.62% | -23.34 | 0.00% | 0.00% | |
| Neutral | $75.4B | -44.29% | -24.08 | -12.57% | 0.00% | |
| StrongBuy | $132.5B | 180.98% | 30.19 | 86.04% | 0.00% | |
| Buy | $78.1B | 28.80% | 17.67 | 84.86% | 0.50% |
Stock Returns calculator for Rapport Therapeutics, Inc. Stock including INR - Dollar returns
The Rapport Therapeutics, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
Rapport Therapeutics, Inc. investment value today
Current value as on today
₹1,22,329
Returns
₹22,329
(+22.33%)
Returns from Rapport Therapeutics, Inc. Stock
₹12,719 (+12.72%)
Dollar Impact
₹9,610 (+9.61%)
Analyst Recommendation on Rapport Therapeutics, Inc. Stock
Based on 9 analysts
100.00%
Buy
0.00%
Hold
0.00%
Sell
Based on 9 analysts, 100% of analysts recommend a 'BUY' rating for Rapport Therapeutics, Inc.. Average target price of $61.8
Indian Investors' Interest in Rapport Therapeutics, Inc. Stock
Search interest for Rapport Therapeutics, Inc. Stock has increased by 80% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:80% versus previous 30 day period
Rapport Therapeutics, Inc. Quarterly Profit & Loss
All numbers in Millions USD
Rapport Therapeutics, Inc. Annual Profit & Loss
All numbers in Millions USD
Rapport Therapeutics, Inc. Quarterly Cash Flow
All numbers in Millions USD
Rapport Therapeutics, Inc. Annual Cash Flow
All numbers in Millions USD
Insights on Rapport Therapeutics, Inc.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
NO EFFECTAgainst Peers
In the last 1 year, Moderna, Inc. Common Stock has given 566.9% return, outperforming this stock by 554.2%
NEGATIVE IMPACTPrice Dip
In the last 1 month, RAPP stock has moved down by -29.7%
About Rapport Therapeutics, Inc.
| Organisation | Rapport Therapeutics, Inc. |
| Headquarters | 99 High Street, Boston, MA, 02110, US |
| Industry | Biotechnology |
| CEO | Abraham N. Ceesay |
Key Management of Rapport Therapeutics, Inc.
Name | Title |
|---|---|
Ms. Cheryl Gault | Chief Operating Officer |
Ms. Julie DiCarlo | Head of Communications & Investor Relations |
Mr. Swamy Yeleswaram Ph.D. | Chief Development Officer |
Mr. Abraham N. Ceesay M.B.A. | CEO, President, Treasurer & Director |
Mr. Troy A. Ignelzi | Chief Financial Officer |
Dr. David Bredt M.D., Ph.D. | Founder & Chief Scientific Officer |
Ms. Karina Chmielewski | Chief Information Officer & Head of Operations |
Ms. Kathleen A. Wilkinson | Chief People Officer |
Dr. Steven M. Paul M.D. | Founder & Independent Chairman |
Dr. Jeffrey Sevigny M.D. | Chief Medical Officer |
FAQs
What is Rapport Therapeutics, Inc. share price today?
Rapport Therapeutics, Inc. share price today is $32.17 as on at the close of the market. Rapport Therapeutics, Inc. share today touched a day high of $33.66 and a low of $31.77.
What is the 52 week high and 52 week low for Rapport Therapeutics, Inc. share?
Rapport Therapeutics, Inc. share touched a 52 week high of $52.93 on and a 52 week low of $23.75 on . Rapport Therapeutics, Inc. stock price today i.e. is closed at $32.17,which is 39.22% down from its 52 week high and 35.45% up from its 52 week low.
What is Rapport Therapeutics, Inc.'s market capitalisation today?
Rapport Therapeutics, Inc. market capitalisation is $0.00T as on .
How to invest in Rapport Therapeutics, Inc. Stock (RAPP) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Rapport Therapeutics, Inc. on INDmoney app. Click on Buy button.
What is the minimum amount required to buy Rapport Therapeutics, Inc. Stock (RAPP) from India?
Indian investors can start investing in Rapport Therapeutics, Inc. (RAPP) shares with as little as ₹96.300003051758 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹963.00 in Rapport Therapeutics, Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Rapport Therapeutics, Inc. share’s latest price of $32.17 as on October 3, 2026 at 8:46 am IST, you will get 0.3108 shares of Rapport Therapeutics, Inc.. Learn more about
fractional shares .